InvestorsHub Logo
Replies to #326 on Amgen Inc (AMGN)

DewDiligence

05/02/14 6:07 PM

#328 RE: ManyYearsOTC #326

Evolocumab is not exactly under the radar, although I do get a sense that investors take its success for granted.